Youssef Jounaïdi

1.5k citations
41 papers · 1.1k indexed · h-index 21
Topics
Virus-based gene therapy research (12 papers)Neuroscience and Neuropharmacology Research (10 papers)Pharmacogenetics and Drug Metabolism (8 papers)
Partner nations
United StatesChinaFrance

In The Last Decade

Youssef Jounaïdi

40 papers receiving 1.1k citations

Peers

Youssef Jounaïdi
Comparison fields: 5 of 103
  • Molecular Biology 537
  • Oncology 433
  • Pharmacology 382
  • Genetics 262
  • Cancer Research 133
Replace Sébastien Sauvage with:
Sébastien Sauvage Belgium
Ken Ito Japan
Allan S. Wagman United States
Yoonha Hwang United States
Benjamin Le Calvé Belgium
Tie-Yan Han United States
Sonia Martı́nez Spain
Kapila Ratnam United States
John L. Herrmann United States
Claude Dagenais Canada
Youssef Jounaïdi relative to Sébastien Sauvage Belgium Sébastien Sauvage's profile →
Citations per field
00.5×3.2×
Sébastien Sauvage · 1×
Citations per year

Countries citing papers authored by Youssef Jounaïdi

Since Specialization
Citations

This map shows the geographic impact of Youssef Jounaïdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youssef Jounaïdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youssef Jounaïdi more than expected).

Fields of papers citing papers by Youssef Jounaïdi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youssef Jounaïdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youssef Jounaïdi. The network helps show where Youssef Jounaïdi may publish in the future.

Co-authorship network of co-authors of Youssef Jounaïdi

This figure shows the co-authorship network connecting the top 25 collaborators of Youssef Jounaïdi. A scholar is included among the top collaborators of Youssef Jounaïdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youssef Jounaïdi. Youssef Jounaïdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 41
3 5
4 2
5 56
6 4
7 3
8 16
9 29
10 27
11 16
12 2
13 57
14 40
15
Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
52
16 99
17 52
18 38
19 51
20 18

About Youssef Jounaïdi

Youssef Jounaïdi is a scholar working on Pharmacology, Biotechnology and Cellular and Molecular Neuroscience, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), Neuroscience and Neuropharmacology Research (10 papers) and Pharmacogenetics and Drug Metabolism (8 papers). The work is most often cited by research in Pharmacology (382 citations), Oncology (433 citations) and Biotechnology (93 citations). Youssef Jounaïdi has collaborated with scholars based in United States, China and France. Frequent co-authors include David J. Waxman, Patrick Maurel, M.J. Vilarem, Chong-Sheng Chen, Joshua C. Doloff, Stuart A. Forman, Haitao Zhu, Keith W. Miller, Jean‐Marc Pascussi and J Domergue. Their work appears in journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026